Statins as a newly recognized type of immunomodulator.

Cited by (1,001)

Items 301–400 of 1,001

1. The Role of Statins in Prevention and Treatment of Community Acquired Pneumonia: A Systematic Review and Meta-Analysis
   Abdur Rahman Khan, Muhammad Ali Riaz, Aref A. Bin Abdulhak, Mohamad A. Al-Tannir, Musa Abubakar Garbati, Patricia J. Erwin, Larry M. Baddour, Imad M. Tleyjeh · 2013 · PLoS ONE
2. Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled study
   Wojciech Płazak, Krzysztof Gryga, Hanna Dziedzic‐Oleksy, Lidia Tomkiewicz Pająk, Małgorzata Konieczyńska, Piotr Stanisław Podolec, Jacek Musiał · 2011 · Arthritis Research & Therapy
3. Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis
   Alimuddin I. Zumla, Martin Rao, Ernest Dodoo, Markus J. Maeurer · 2016 · BMC Medicine
4. Are statins a treatment option for multiple sclerosis?
   Oliver Neuhaus, Olaf Stüve, Scott S. Zamvil, Hans-Peter Hartung · 2004 · The Lancet Neurology
5. The role of vitamin D deficiency in sepsis and potential therapeutic implications
   Richard Watkins, Alexandra V. Yamshchikov, Tracy L. Lemonovich, Robert A. Salata · 2011 · Journal of Infection
6. Disease modification and cardiovascular risk reduction: two sides of the same coin?
   Frances C. Hall, Nicola Dalbeth · 2005 · Rheumatology
7. The treatment of giant cell arteritis.
   John Alexander Fraser, Cornelia M. Weyand, Nancy J. Newman, Valérie Biousse · 2008 · PubMed
8. Omega-3 Fatty Acids Ameliorate Atherosclerosis by Favorably Altering Monocyte Subsets and Limiting Monocyte Recruitment to Aortic Lesions
   Amanda L. Brown, Xuewei Zhu, Shunxing Rong, Swapnil V. Shewale, Jeongmin Seo, Elena Y. Boudyguina, Abraham K. Gebre, Martha A. Alexander‐Miller, John S. Parks · 2012 · Arteriosclerosis Thrombosis and Vascular Biology
9. HMG-CoA Reductase Inhibitors Inhibit Endothelial Exocytosis and Decrease Myocardial Infarct Size
   Munekazu Yamakuchi, James J.M. Greer, Scott J. Cameron, Kenji Matsushita, Craig N. Morrell, Karen Fox-Talbot, William M. Baldwin, David J. Lefer, Charles J. Lowenstein · 2005 · Circulation Research
10. Potential Correlation between Statins and Pulp Chamber Calcification
    Mary T. Pettiette, Sheng Zhong, Antonio J. Moretti, Asma Wahid Ali khan · 2013 · Journal of Endodontics
11. Lipids and Atherosclerosis: Lessons Learned from Randomized Controlled Trials of Lipid Lowering and Other Relevant Studies
    Robert A. Kreisberg, Albert Oberman · 2002 · The Journal of Clinical Endocrinology & Metabolism
12. Pleiotropic Effects and Cholesterol-Lowering Therapy
    Steven M. Shaw, James E. Fildes, Nizar A. Yonan, Simon G. Williams · 2008 · Cardiology
13. Atorvastatin Inhibits T Cell Activation through 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase without Decreasing Cholesterol Synthesis
    Norbert Blank, Martin R. Schiller, Stefan Krienke, Freja Busse, Birgit Schätz, Anthony Dick Ho, Joachim Robert Kalden, Hanns‐Martin Lorenz · 2007 · The Journal of Immunology
14. Decrease in the Number of Reported Cases of Zygomycosis among Patients with Diabetes Mellitus: A Hypothesis
    Dimitrios P. Kontoyiannis · 2007 · Clinical Infectious Diseases
15. Statins and prostate cancer: Molecular and clinical aspects
    Georgios I. Papadopoulos, Dimitrios Delakas, Lydia Nakopoulou, Theodoros Ioannis Kassimatis · 2011 · European Journal of Cancer
16. Immunomodulation by statins: mechanisms and potential impact on autoimmune diseases
    Sek C. Chow · 2009 · Archivum Immunologiae et Therapiae Experimentalis
17. Simvastatin reduces MMP-3 level in interleukin 1β stimulated human chondrocyte culture
    Pietro Enea Lazzerini, P.L. Capecchi, Fabiola Nerucci, A Fioravanti, Francesca Chellini, Monica Piccini, Stefania Bisogno, R Marcolongo, Franco Laghi Pasini · 2004 · Annals of the Rheumatic Diseases
18. Role of Macrophages in Cardioprotection
    Jonathan Yap, Héctor A. Cabrera-Fuentes, Jason S. Irei, Derek John Hausenloy, William A. Boisvert · 2019 · International Journal of Molecular Sciences
19. Suppression of Autoimmune Retinal Disease by Lovastatin Does Not Require Th2 Cytokine Induction
    Matthew E. Gegg, Rachel A. Harry, Deborah J.R. Hankey, Hadi Zambarakji, Gareth Pryce, David Baker, Peter Adamson, Virginia L. Calder, John Greenwood · 2005 · The Journal of Immunology
20. Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats
    Wei Liu, Weimin Li, Cheng Gao, Ningling Sun · 2005 · Journal of Autoimmunity
21. The Pleiotropic Effects of HMG-CoA Reductase Inhibitors
    Alla Waldman, Leonard Kritharides · 2003 · Drugs
22. Statins in the treatment of central nervous system autoimmune disease
    Martin S. Weber, Sawsan Youssef, Shannon E. Dunn, Thomas Prod’homme, Oliver Neuhaus, Olaf Stüve, John Greenwood, Lawrence Steinman, Scott S. Zamvil · 2006 · Journal of Neuroimmunology
23. Rationale for the use of statins in liver disease
    Robert Schierwagen, Frank Erhard Uschner, Fernando Magdaleno, Sabine Klein, Jonel Trebicka · 2017 · American Journal of Physiology-Gastrointestinal and Liver Physiology
24. Interplay between hypercholesterolaemia and inflammation in atherosclerosis: Translating experimental targets into clinical practice
    José Tuñón, Magnus Bäck, Lina Badimón, Marie‐Luce Bochaton‐Piallat, Bertrand Cariou, Mat J.A.P. Daemen, Jesús Egido, Paul Charles Evans, Sheila Francis, Daniel F.J. Ketelhuth et al. · 2018 · European Journal of Preventive Cardiology
25. Lipaemia, Inflammation and Atherosclerosis
    A.J.H.H.M. van Oostrom, Jeroen P. H. van Wijk, Manuel Castro Cabezas · 2004 · Drugs
26. Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells
    Xiao-Li Li, Ying‐Chun Dou, Ying Liu, Shi Chang-wen, Lili Cao, Xiuqing Zhang, Jie Zhu, Rui‐Sheng Duan · 2011 · Cellular Immunology
27. Pravastatin attenuates allergic airway inflammation by suppressing antigen sensitisation, interleukin 17 production and antigen presentation in the lung
    Mitsuru Imamura, Katsuhide Okunishi, Hiroshi Ohtsu, Kazuyuki Nakagome, H Harada, Ryoichi Tanaka, Kazuo Yamamoto, Makoto Dohi · 2008 · Thorax
28. Interferon-γ Induces Major Histocompatibility Class II Transactivator (CIITA), Which Mediates Collagen Repression and Major Histocompatibility Class II Activation by Human Aortic Smooth Muscle Cells
    Giovanna Butticè, J. Miller, Lin Wang, Barbara D. Smith · 2006 · Circulation Research
29. Treatment of hyperlipidemia in cardiac transplant recipients
    Kenneth C. Bilchick, Charles A. Henrikson, Diane V. Skojec, Edward K. Kasper, Roger Scott Blumenthal · 2004 · American Heart Journal
30. Effects of atorvastatin on reactive hyperaemia and the thrombosis–fibrinolysis system in patients with heart failure
    Dimitris Tousoulis, C Antoniades, E Bosinakou, M Kotsopoulou, C Tsioufis, C Tentolouris, A Trikas, C Pitsavos, Christodoulos Stefanadis · 2004 · Heart
31. Atorvastatin-induced dermatomyositis
    Bernard Noël, Jean‐Philippe Cerottini, Renato G. Panizzon · 2001 · The American Journal of Medicine
32. Enhancing Effect of Dietary Cholesterol and Inhibitory Effect of Pravastatin on Allergic Pulmonary Inflammation
    Ya-Fan Yeh, Song‐Lih Huang · 2004 · Journal of Biomedical Science
33. Statins enhance the effects of corticosteroids on the balance between regulatory T cells and Th17 cells
    Kittipong Maneechotesuwan, Kanda Kasetsinsombat, Valla Wamanuttajinda, Adisak Wongkajornsilp, Peter John Barnes · 2012 · Clinical & Experimental Allergy
34. New tricks for old dogs: countering antibiotic resistance in tuberculosis with host‐directed therapeutics
    Thomas R. Hawn, Javeed Ali Shah, Daniel Kalman · 2015 · Immunological Reviews
35. Effects of low-dosage simvastatin on rheumatoid arthritis through reduction of Th1/Th2 and CD4/CD8 ratios
    Hiroko Kanda, Kazuhiro Yokota, Chieko Kohno, Tetsuji Sawada, Kojiro Sato, Masao Yamaguchi, Yoshinori Komagata, Kota Shimada, Kazuhiko Yamamoto, Toshihide Mimura · 2007 · Modern Rheumatology
36. Statin treatment is associated with a decreased risk of active tuberculosis: an analysis of a nationally representative cohort
    Chih‐Cheng Lai, Meng-tse Gabriel Lee, Shih-Hao Lee, Wan‐Ting Hsu, Shy-Shin Chang, Shyr‐Chyr Chen, Chien‐Chang Lee · 2016 · Thorax
37. Impact of HMG-CoA reductase inhibition on brain pathology
    Frauke Zipp, Sonia Waiczies, Orhan Aktaş, Oliver Neuhaus, Bernhard Hemmer, Burkhard Schraven, Robert Nitsch, Hans‐Peter Hartung · 2007 · Trends in Pharmacological Sciences
38. The Use of Statins in Pediatrics: Knowledge Base, Limitations, and Future Directions
    Brook Belay, Peter F. Belamarich, Catherine Tom-Revzon · 2007 · PEDIATRICS
39. HMG-CoA reductase promotes protein prenylation and therefore is indispensible for T-cell survival
    Lacher, Sonja M, Bruttger, Julia, Kalt, Bettina, Berthelet, Jean, Rajalingam, Krishnaraj, Wörtge, Simone, Waisman, Ari · 2017 · Cell Death & Disease
40. Fluvastatin inhibits raft dependent Fcγ receptor signalling in human monocytes
    Dianne Z. Hillyard · 2003 · Atherosclerosis
41. Pluripotential Mechanisms of Cardioprotection with HMG-CoA Reductase Inhibitor Therapy
    Robert S. Rosenson · 2001 · American Journal of Cardiovascular Drugs
42. HMG-CoA Reductase Inhibition: Anti-Inflammatory Effects beyond Lipid Lowering?
    Winfried März, Wolfgang Köenig · 2003 · European Journal of Cardiovascular Prevention & Rehabilitation
43. Interrelationship of Free Oxygen Radicals and Endothelial Dysfunction--Modulation by Statins
    Sven Waßmann, Georg Nickenig · 2003 · Endothelium
44. Donor dependent, interferon-γinduced HLA-DR expression on human neutrophilsin vivo
    Walter Reinisch, Cornelia Lichtenberger, Guenther G. Steger, Wolfgang Tillinger, Otto Scheiner, Alfred Gangl, Dieter Maurer, Martin Willheim · 2003 · Clinical & Experimental Immunology
45. Global Analysis of RNA Expression Profile in Human Vascular Cells Treated with Statins
    Shigeru Morikawa, Wakako Takabe, Chikage Mataki, Yoichiro Wada, Akashi Izumi, Yasushi Saitō, Takao Hamakubo, Tatsuhiko Kodama · 2004 · Journal of Atherosclerosis and Thrombosis
46. Dual effect of statin medication on the periodontium
    Tuomas Saxlin, Liisa Suominen‐Taipale, Matti Lauri Edvard Knuuttila, Pirkko Alha, Pekka Ylöstalo · 2009 · Journal Of Clinical Periodontology
47. Atorvastatin Induces T Cell Anergy via Phosphorylation of ERK1
    Sonia Waiczies, Tim Prozorovski, Carmen Infante‐Duarte, Astrid Hahner, Orhan Aktaş, Oliver Ullrich, Frauke Zipp · 2005 · The Journal of Immunology
48. Inflammatory Biomarkers, Statins, and the Risk of Stroke
    Paul M. Ridker · 2002 · Circulation
49. Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo.
    Martin Noël, Claude Gagné, Jean Bergeron, Jean Jobin, Paul Poirier · 2004 · Lipids in Health and Disease
50. Multifunctional Actions of Approved and Candidate Stroke Drugs
    Jens Minnerup, Wolf‐Rüdiger Schäbitz · 2008 · Neurotherapeutics
51. Coenzyme Q10 levels are low and may be associated with the inflammatory cascade in septic shock
    Michael William Donnino, Michael N. Cocchi, Justin D. Salciccioli, Daniel Kim, Ali Naini, Catherine Buettner, Praveen Akuthota · 2011 · Critical Care
52. Macrophage Heterogeneity and Plasticity: Impact of Macrophage Biomarkers on Atherosclerosis
    Joselyn Rojas, Juan José Salazar, María Sofía Martínez, Jim Palmar, Jordan Bautista, Mervin Chávez-Castillo, Alexis Gómez, Valmore Bermúdez · 2015 · Scientifica
53. The role of Inflammation, humoral and cell mediated autoimmunity in the pathogenesis of atherosclerosis
    Pereira Alves, Eduardo Ferreira Borba · 2008 · Swiss Medical Weekly
54. Simvastatin inhibits lymphocyte function in normal subjects and patients with cardiovascular disease
    Dianne Z. Hillyard · 2004 · Atherosclerosis
55. Rho‐GTPase and Atherosclerosis: Pleiotropic Effects of Statins
    Anping Cai, Yingling Zhou, Liwen Li · 2015 · Journal of the American Heart Association
56. White Blood Cell Count Predicts Reduction in Coronary Heart Disease Mortality With Pravastatin
    Ralph Stewart, Harvey Douglas White, Adrienne C Kirby, Stephane R. Heritier, Robert John Simes, Paul John Nestel, Malcolm West, David M. Colquhoun, Andrew Maxwell Tonkin · 2005 · Circulation
57. Cardiovascular disease in lupus patients: Should all patients be treated with statins and aspirin?
    Ian N Bruce · 2005 · Best Practice & Research Clinical Rheumatology
58. Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treatment of MS
    Scott S. Zamvil, Lawrence Steinman · 2002 · Neurology
59. Role of the MHC2TA gene in autoimmune diseases
    Alfonso Martínez, Marta Sánchez-López, Jezabel Varadé, Ana Isabel Rosell Mas, M Carmen Martín, Virginia de las Heras, Rafael Arroyo, Juan L. Mendoza, Manuel Díaz‐Rubio, Benjamín Fernández‐Gutiérrez et al. · 2006 · Annals of the Rheumatic Diseases
60. Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflammation
    Fabio Fischetti I, Renzo Carretta, G. Borotto, Paolo Durigutto, Roberta Bulla, Pier Luigi Meroni, Francesco Tedesco · 2004 · Clinical & Experimental Immunology
61. Lovastatin inhibits bone marrow-derived dendritic cell maturation and upregulates proinflammatory cytokine production
    Dongxu Sun, Gabriel Fernandes · 2003 · Cellular Immunology
62. Atorvastatin reduces T ‐cell activation and exhaustion among HIV ‐infected c ART ‐treated suboptimal immune responders in U ganda: a randomised crossover placebo‐controlled trial
    Damalie Nakanjako, Isaac Ssinabulya, Rose Nabatanzi, Lois Bayigga, Agnes N Kiragga, Moses Lutaakome Joloba, Pontiano Kaleebu, Andrew Ddungu Kambugu, Moses Robert Kamya, Rafick‐Pierre Sékaly et al. · 2014 · Tropical Medicine & International Health
63. Pravastatin improves renal ischemia–reperfusion injury by inhibiting the mevalonate pathway
    Satoru Sharyo, Naoko Yokota‐Ikeda, Miyuki Mori, Kazuyoshi Kumagai, Kazuyuki Uchida, Katsuaki Ito, Melissa J. Burne-Taney, Hamid Rabb, Masahiro Ikeda · 2008 · Kidney International
64. Simvastatin Regulates Myocardial Cytokine Expression and Improves Ventricular Remodeling in Rats after Acute Myocardial Infarction
    Jinying Zhang, Xiang Chao Cheng, Yuhua Liao, Baojun Lu, Yali Yang, Bin Li, Hongxia Ge, Min Wang, Ying Liu, Zhangqiang Guo et al. · 2005 · Cardiovascular Drugs and Therapy
65. Antigen-specific immune reactions to ischemic stroke
    Xabier Urra, Francesc Miró‐Mur, Ángel Chamorro, Anna Maria Planas · 2014 · Frontiers in Cellular Neuroscience
66. A multicolour fluorescence in situ hybridization test predicts recurrence in patients with high‐risk superficial bladder tumours undergoing intravesical therapy
    Jared Myers Whitson, Anna Belinda Berry, Peter R. Carroll, Badrinath R. Konety · 2009 · British Journal of Urology
67. The effect of statins and fibrates on interferon-γ and interleukin-2 release in patients with primary type II dyslipidemia
    Bogusław Okopień, Robert G. Krysiak, Jan Kowalski, Andrzej Madej, Dariusz Belowski, Marek Zieliński, Krzysztof Łabuzek, Zbigniew Stanislaw Herman · 2004 · Atherosclerosis
68. Arterial Inflammation and Atherosclerosis
    Burkhard Ludewig · 2002 · Trends in Cardiovascular Medicine
69. Effect of Simvastatin, an Established Lipid-Lowering Drug, on Pulmonary Chlamydia pneumoniae Infection in Mice
    Leena Erkkilä, Matti Jauhiainen, Kirsi Laitinen, Kristiina Haasio, Terttu M. Tiirola, Pekka Saikku, Maija Leinonen · 2005 · Antimicrobial Agents and Chemotherapy
70. Molecular Mechanisms of Neuroimmune Crosstalk in the Pathogenesis of Stroke
    Y. Choi, C. Laaker, Martin Hsu, Peter Cismaru, M. Sandor, Z. Fabry · 2021 · International Journal of Molecular Sciences
71. The Acyl-Coenzyme A: Cholesterol Acyltransferase Inhibitor CI-1011 Reverses Diffuse Brain Amyloid Pathology in Aged Amyloid Precursor Protein Transgenic Mice
    Henri J. Huttunen, Daniel Havas, Camilla Peach, Cory Barren, Stephan Duller, Weiming Xia, Matthew P. Frosch, Birgit Hutter‐Paier, Manfred Windisch, Dora M. Kovacs · 2010 · Journal of Neuropathology & Experimental Neurology
72. Drug disease interactions: role of inflammatory mediators in disease and variability in drug response.
    Kenneth M. Kulmatycki, Fakhreddin Jamali · 2005 · PubMed
73. Phosphorylation of Endothelial Nitric-Oxide Synthase Is Diminished in Mesenteric Arteries from Septic Rabbits Depending on the Altered Phosphatidylinositol 3-Kinase/Akt Pathway: Reversal Effect of Fluvastatin Therapy
    Naoyuki Matsuda, Yukio Hayashi, Yoshika Takahashi, Yuichi Hattori · 2006 · Journal of Pharmacology and Experimental Therapeutics
74. Polymyosites induites ou associées aux traitements hypolipémiants ?
    A.L. Fauchais, J Iba Ba, Pierre Maurage, X Kyndt, D Bataille, Eric HACHULLA, D Parent, Viviane Queyrel, M. Lambert, U Michon Pasturel et al. · 2003 · La Revue de Médecine Interne
75. Statin (cerivastatin) protects mice against sepsis-related death via reduced proinflammatory cytokines and enhanced bacterial clearance.
    Chaudhry, Mohammad Z., Wang, Jiang Huai, Blankson, Siobhan, Redmond, H. Paul · 2008 · Surgical Infections
76. Macrophage-based therapeutic approaches for cardiovascular diseases
    Marida Sansonetti, Bashar Al Soodi, Thomas Thum, Mira Jung · 2024 · Basic Research in Cardiology
77. Intake of Fish Oil, Oleic Acid, Folic Acid, and Vitamins B-6 and E for 1 Year Decreases Plasma C-Reactive Protein and Reduces Coronary Heart Disease Risk Factors in Male Patients in a Cardiac Rehabilitation Program
    Juan Jesús Carrero, Juristo Fonollá, José Luis Marti, Jesús Jiménez, J. Bozá, Eduardo López‐Huertas · 2007 · Journal of Nutrition
78. Simvastatin improves the healing of infected skin wounds of rats
    Amália Cínthia Meneses do Rêgo, Irami Araújo-Filho, Bolívar Ponciano Goulart de Lima Damasceno, Eryvaldo Sócrates Tabosa do Egito, Ivanaldo Amâncio da Silveira, José Brandão‐Neto, Aldo Cunha Medeiros · 2007 · Acta Cirúrgica Brasileira
79. Immunomodulatory treatment of immune checkpoint inhibitor-induced myocarditis: Pathway toward precision-based therapy
    Dinu Valentin Balanescu, Teodora Donisan, Nicolas L. Palaskas, Juan Lopez‐Mattei, Peter Y. Kim, Louis Maximilian Buja, Dennis M. McNamara, JON A. KOBASHIGAWA, Jean‐Bernard Durand, Cezar Iliescu · 2020 · Cardiovascular Pathology
80. Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease
    Hannes Franz Alber, Józef Dulak, Matthias Frick, Wolfgang Dichtl, Severin P. Schwarzacher, Otmar M. Pachinger, Franz F. Weidinger · 2002 · Journal of the American College of Cardiology
81. N-acetyl-L-cysteine ameliorates the inflammatory disease process in experimental autoimmune encephalomyelitis in Lewis rats
    Romesh Stanislaus, Anne Genevieve Gilg, Avtar Kaur Singh, Inderjit Singh · 2005 · Journal of Autoimmune Diseases
82. Statins for the Treatment of Antiphospholipid Syndrome?
    Praveen Jajoria, Vijaya L. Murthy, Elizabeth Papalardo, Zurina Romay‐Penabad, Caroline E. Gleason, Silvia S. Pierangeli · 2009 · Annals of the New York Academy of Sciences
83. Immunosuppression for heart transplantation: where are we now?
    JON A. KOBASHIGAWA, Jignesh K. Patel · 2006 · Nature Clinical Practice Cardiovascular Medicine
84. Macrophage Heterogeneity: Relevance and Functional Implications in Atherosclerosis
    J. Lauran Stöger, Pieter Goossens, Menno P.J. de Winther · 2010 · Current Vascular Pharmacology
85. Systematic review of the in vitro effects of statins on oral and perioral microorganisms
    Miriam Ting, Eugene J. Whitaker, Jasim M. Albandar · 2015 · European Journal Of Oral Sciences
86. Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer
    Takuji Hayashi, Kazutoshi Fujita, Makoto Matsushita, Norio Nonomura · 2019 · Cancers
87. Is Dressler Syndrome Dead?
    Karim Bendjelid, Jérôme Pugin · 2004 · CHEST Journal
88. Statins in Solid Organ Transplantation: Is There an Immunosuppressive Effect?
    JON A. KOBASHIGAWA · 2004 · American Journal of Transplantation
89. Statin-Regulated Efferocytosis in Physiological and Pathological Conditions
    Amir Tajbakhsh, Seyed Mohammad Gheibi Hayat, Hassan Askari, Amir Savardashtaki, Matteo Pirro, Thomas Patrick Johnston, Amirhossein Sahebkar · 2022 · Pharmacology & Therapeutics
90. Treatment with statins does not exhibit a clinically relevant corticosteroid‐sparing effect in patients with giant cell arteritis
    Ana García‐Martínez, José Hernández‐Rodríguez, Josep Maria Grau, Maria Cinta Cid · 2004 · Arthritis Care & Research
91. Atorvastatin Modulates Th1/Th2 Response in Patients With Chronic Heart Failure
    Xiang Chao Cheng, Yingjun Ding, Chunyan Xia, Tingting Tang, Xianjun Yu, Jiang-jiao Xie, Mengyang Liao, Rui Yao, Yong Chen, Min Wang et al. · 2008 · Journal of Cardiac Failure
92. Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis
    Jennifer M. P. Woo, Zhuofeng Lin, Mohamad Navab, Casey Van Dyck, Yvette Trejo-Lopez, Krystal M. T. Woo, Hongyun Li, Lawrence W. Castellani, Xuping Wang, Noriko Iikuni et al. · 2010 · Arthritis Research & Therapy
93. Statin use and the risk of Clostridium difficile in academic medical centres
    Christine Motzkus, Amy L. Pakyz, Ronald E. Polk, Giovanni Gambassi, Kate L. Lapane · 2012 · Gut
94. Inhibition of Rho Family GTPases Results in Increased TNF-α Production After Lipopolysaccharide Exposure
    Martha M. Monick, Linda S. Powers, Noah S. Butler, Gary W. Hunninghake · 2003 · The Journal of Immunology
95. Immunomodulation for treatment and prevention of atherosclerosis
    Yaniv Sherer, Yehuda Shoenfeld · 2002 · Autoimmunity Reviews
96. A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma
    Yikai Wang, Wenjun Wang, Muqi Wang, Juanjuan Shi, Xiaoli Jia, Shuangsuo Dang · 2022 · Canadian Journal of Gastroenterology and Hepatology
97. The role of statins in clinical medicine -LDL - cholesterol lowering and beyond
    Jonas Rutishauser · 2006 · Swiss Medical Weekly
98. The Effect of Rosuvastatin in a Murine Model of Influenza A Infection
    Kathryn A. Radigan, Daniela Urich, Alexander V. Misharin, Sergio E. Chiarella, Saul Soberanes, Angel Gonzalez, Harris Perlman, Richard G. Wunderink, G. R. Scott Budinger, Gökhan M. Mutlu · 2012 · PLoS ONE
99. Successful Treatment of Acute Lung Injury with Pitavastatin in Septic Mice: Potential Role of Glucocorticoid Receptor Expression in Alveolar Macrophages
    Ken-ichi Takano, Seiji Yamamoto, Kengo Tomita, Michinori Takashina, Hiroki Yokoo, Naoyuki Matsuda, Yasuo Takano, Yuichi Hattori · 2010 · Journal of Pharmacology and Experimental Therapeutics
100. Potential Immunomodulatory Effects of Statins in Inflammatory Bowel Disease
     Justin Côté-Daigneault, Saurabh Mehandru, Ryan C. Ungaro, Ashish Atreja, Jean‐Frédéric Colombel · 2016 · Inflammatory Bowel Diseases